Does high-dose buprenorphine cause respiratory depression?: possible mechanisms and therapeutic consequences.
about
Endogenous opiates and behavior: 2006Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options.The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence.Long-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: the case of Sweden.Buprenorphine vs methadone treatment: A review of evidence in both developed and developing worlds.Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review.Intravenous buprenorphine and norbuprenorphine pharmacokinetics in humans.Effect of anti-NGF antibodies in a rat tibia fracture model of complex regional pain syndrome type I.Use of Medicines from the Group of Benzodiazepines in the Period of 2003-2013 Year in the Republic of Macedonia.Indicators of buprenorphine and methadone use and abuse: what do we know?Induction of pregnant women onto opioid-agonist maintenance medication: an analysis of withdrawal symptoms and study retention.Illicit use of methadone and buprenorphine among adolescents and young adults in SwedenTreatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial.Benzodiazepines, methadone and buprenorphine: interactions and clinical management.Efficacy and ligand bias at the μ-opioid receptor.Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2).Buprenorphine treatment for narcotic addiction: not without risks.A urinalysis-based study of buprenorphine and non-prescription opioid use among patients on buprenorphine maintenance.Diversion of methadone and buprenorphine from opioid substitution treatment: patients who regularly sell or share their medication.Diversion of buprenorphine/naloxone coformulated tablets in a region with high prescribing prevalence.Buprenorphine in the treatment of opiate dependence.Randomised Comparison of a Novel Buprenorphine Oral Lyophilisate versus Existing Buprenorphine Sublingual Tablets in Opioid-Dependent Patients: A First-in-Patient Phase II Randomised Open Label Safety Study.Suicide by Medication Overdose in Prison: A Study of Three Cases.An unusual case of death probably triggered by the association of buprenorphine at therapeutic dose with ethanol and benzodiazepines and with very low norbuprenorphine level.Misuse of buprenorphine maintenance treatment since introduction of its generic forms: OPPIDUM survey.
P2860
Q28752585-7FFD6CA5-6549-4C08-B898-6845790BA044Q33688813-62E58BAC-33DC-42F0-A347-DF252B41DF60Q33870389-86D5CD3C-9AE0-47A5-9055-1F7E0067FB84Q35109559-649D417A-7374-4447-830C-824B084B4812Q35733030-C03F831B-B863-4B0A-839D-7D830532F0CFQ35906594-76F731AF-13CE-451C-BD9C-66620FDFC778Q36874673-8259208B-303C-4D00-882E-747075BB02F9Q36881864-435CF8FD-665F-4A93-8F29-5A17DBC35D15Q36929060-087D3139-73F1-42B2-BCE4-031AC1C34707Q37045326-A3EB335B-BD07-42C7-AB69-A5A4AAC21D07Q37067368-CCAEB2F1-87A2-45A9-A639-A6CDE63AC790Q37369585-DDA8458C-F6BA-444A-91D3-5B35811AAD67Q37625536-9FE0560C-5A80-4543-A82A-0E893F42850AQ37687450-5123D152-6BC8-44E7-B91A-7FEAFD47D3BFQ38104365-C796C323-425C-4A8E-A063-04822492F4C2Q39779618-87213740-0A70-4A84-B3D7-0AA942333C8DQ40283005-5B51D8E2-F8C8-4926-B74E-D2B819498EADQ41408098-46823BDD-5882-4A08-A64D-25391B8A38C6Q41703547-938F1940-B7F0-4C75-8CD6-BEFF815C470AQ42649099-CFB0EA30-182C-444B-A57E-3FBC03AA46B4Q42962930-821D4B02-BA92-41BD-A820-5D263A574D38Q44343800-E66423C7-E552-4350-B27C-10291C18D979Q47591438-938485C7-D598-407C-8231-D8FC7D7589C9Q48185747-0B14AEBB-70CE-451F-9510-5F58B302532BQ51173415-1B83D4C9-1348-427B-8110-B2A2B16BAFE5
P2860
Does high-dose buprenorphine cause respiratory depression?: possible mechanisms and therapeutic consequences.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Does high-dose buprenorphine c ...... and therapeutic consequences.
@ast
Does high-dose buprenorphine c ...... and therapeutic consequences.
@en
type
label
Does high-dose buprenorphine c ...... and therapeutic consequences.
@ast
Does high-dose buprenorphine c ...... and therapeutic consequences.
@en
prefLabel
Does high-dose buprenorphine c ...... and therapeutic consequences.
@ast
Does high-dose buprenorphine c ...... and therapeutic consequences.
@en
P2093
P1476
Does high-dose buprenorphine c ...... and therapeutic consequences.
@en
P2093
Frédéric J Baud
Nicolas Marie
Raymond Hreiche
Stéphane Pirnay
P2860
P356
10.2165/00139709-200625020-00002
P577
2006-01-01T00:00:00Z
P5875
P6179
1025944145